1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Generic Drug

The Business of Generics: Market Trends & Strategies Explained

  • Currently 4/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
57 votes

Topics under Generic Drug

Global Generic Drug Industry

The generic drug industry (as a part of the pharmaceutical business) covers the marketing and sale of medication containing the same active ingredients and dosages as brand-name drugs manufactured by the pharmaceutical industry. Drugs can be prescribed under their chemical name without specifying a particular pharmaceutical brand or company. A key benefit of generic drugs is that they usually cost a fraction of the price of brand-name drugs, as much as 80% to 85% less according to the US Food and Drug Administration. For example, Glucotrol, a drug used in the treatment of diabetes, represents a monthly cost to patients of between $42 and $84 for 10 mg tablets; however, the drug’s generic version, Glipizide, costs up to 10 times less at between $4 and $8 per month.

Generic drugs are under the same governance as brand-name drugs and must adhere to the same standards. When brand-name drugs come off patent, the market is opened up to generic versions. Patent protection generally protects a drug’s intellectual property rights for about 20 years, but as the patent is effective from the clinical trial stage, the actual time the drug is on the market can be far less, often between 10 and 14 years. After a patent expires, pharmaceutical companies come under fierce pricing pressure due to competition from their less-expensive generic counterparts.

Generics help reduce government spending on healthcare, accounting in part for a near 5% decrease in US drug spending, reports the FDA. The FDA acts as a governing body for generic drugs to enforce maximum standards of variation with brand-name drugs. However, in an 11-year study, variation in absorption of branded and generic drugs was found to be as little as 3.5%. Such negligible variation could equally exist in a comparison of two branded drugs.

Best-Selling Generic Drugs

Generic drugs took all of the top-10 spots for the most-prescribed drugs in the US last year, as ranked by the IMS Institute for Healthcare Informatics. Only three brand-name drugs ranked in the top 25, highlighting the strong foothold secured by generics.

Possibly further boosting future sales is the looming patent expiration of several of the pharmaceutical world’s star prescription brand-name drugs, for which generics are poised to claim a sizeable market share. Top generic drugs to enter the market this year are expected to be Methylphenidate (an attention deficit hyperactivity disorder drug taking over from Concerta) and Levofloxacin (a copy of antibiotic Levaquin).

Other generics set to take over from brand-name drugs include:

  • Fenofibrate based on the cholesterol drug Tricor
  • Montelukast based on asthma and allergy treatment Singulair
  • Pioglitazone based on the diabetic drug Actos
  • Valsartan based on the high blood pressure medication Diovan

Industry Leaders

BCC Research shows Teva Pharmaceutical Industries to hold just under 20% of the global generic drugs market, followed by Sandoz, with 10% of the market. In joint third place are Watson and Mylan, with 6% each. Together, Teva, Sandoz, Watson, and Mylan hold a combined 40% share of the global market.

Generic Drug Industry Trends

The generic drug market is gaining increasing ground over brand-name pharmaceuticals, with the FDA reporting that generics account for more than 70% of prescription drugs in the US. 


Leading Associations

You might be interested in these related markets:

Customer Support

Talk to Sam

+852 5808 2421

23 Reports
Demand, Market Size, Company
65 Statistics
Market Size, Demand, Finance
120 Reports
Demand, Litigation And Patent, Supply
360 Statistics
Market Size, Demand, Finance
23 Reports
Market Size, Demand, Supply
46 Statistics
Market Size, Demand, Finance
9 Reports
Supply, Market Size, Market Shares
12 Statistics
Market Size, Demand, Market Shares
22 Reports
Market Size, Trade, Supply
120 Statistics
Market Size, Demand, Finance
9 Reports
Supply, Demand, Market Size
22 Statistics
Market Size, Demand, Market Shares
8 Reports
Demand, Market Size, Price
10 Statistics
Market Size, Demand, Price
11 Reports
Demand, Company Financials, Company
81 Statistics
Market Size, Demand, Company Financials
3 Reports
Market Size, Demand, Market Shares
2 Statistics
Market Size, Demand, Market
19 Reports
Market Size, Demand, Supply
29 Statistics
Market Size, Demand, Company
Search in Generic Drug Industry (About 400 reports)
Parent industry: Pharmaceutical
Related industries: Drug Delivery, Drug Discovery and Development, OTC, Prescription Drug, Therapy

About 100 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 495 - $ 4000)

Global Generics Industry Profile & Value Chain Analysis

Global Generics Industry Profile & Value Chain Analysis Company Report

  • $ 495
  • Industry report
  • March 2018
  • by MarketLine

Global Generics Industry Profile & Value Chain AnalysisSummaryGlobal Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume ...

Generic Drugs Markets in China $ 4000 May 2018

GENERIC DRUGS MARKET FORECAST 2018-2028 $ 3628 April 2018

Pharma Leader Series: Top Generic Drug Producers Market ... $ 3628 July 2017

Generic Oral Liquid Dosage Forms $ 2850 January 2017

Generic Drugs Companies in China $ 1800 May 2018

Generic Drugs Industry Forecasts - China Focus $ 1800 May 2018

GCC Generic Drug Market: Industry Trends, Share, Size, ... $ 1799 April 2018

Generic Drugs Market: Global Industry Trends, Share, Si ... $ 1799 April 2017

United States Generic Drugs Market, By Therapeutic Appl ... $ 1590 June 2018

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on